Cysteine proteinases and matrix metalloproteinases play distinct roles in the subosteoclastic resorption zone

Journal of Bone and Mineral Research

Volumn 13, Issue 9, 1998, Pages 1420-1430

  Everts, Vincent ^a,b,d   Delaissé, Jean Marie ^c   Korper, Wolf ^a   Beertsen, Wouter ^b  

^a Experimental Oral Biology Group   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c CENTER FOR CLINICAL AND BASIC RESEARCH   (Denmark)

^d ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTEINE PROTEINASE; MATRIX METALLOPROTEINASE;

ANIMAL TISSUE; ARTICLE; BONE DEMINERALIZATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ANALYSIS; MICROSCOPY; MORPHOMETRICS; MOUSE; NONHUMAN; OSTEOCLAST; OSTEOLYSIS;

AMIDES; AMINO ACIDS, BRANCHED-CHAIN; ANIMALS; BONE MATRIX; BONE RESORPTION; CELLS, CULTURED; CYSTEINE ENDOPEPTIDASES; CYSTEINE PROTEINASE INHIBITORS; DIPEPTIDES; HYDROGEN-ION CONCENTRATION; LEUCINE; METALLOENDOPEPTIDASES; MICE; MORPHOLINES; OSTEOCLASTS; PROTEASE INHIBITORS; SKULL; TIME FACTORS;

EID: 0031659890     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/jbmr.1998.13.9.1420     Document Type: Article

References (49)

1. Baron R, Neff L, Louvard D, Courtoy PJ 1985 Cell-mediated extracellular acidification and bone resorption: Evidence for a low pH in resorbing lacunae and localization of a 100-kD lysosomal membrane protein at the osteoclast ruffled border. J Cell Biol 101:2210-2222.
2. Delaissé JM, Vaes G 1992 Mechanism of mineral solubilization and matrix degradation in osteoclastic bone resorption. In: Rifkin BR and Gay CV (eds.) Biology and Physiology of the Osteoclast. CRC Press, Boca Raton, FL, U.S.A., pp. 289-314.
3. Delaissé JM, Eeckhout Y, Vaes G 1980 Inhibition of bone resorption in culture by inhibitors of thiol proteinases. Biochem J 192:365-368.
4. Delaissé JM, Eeckhout Y, Vaes G 1984 In vivo and in vitro evidence for the involvement of cysteine proteinases in bone resorption. Biochem Biophys Res Commun 125:441-447.
5. Delaissé JM, Boyde A, Maconnachie E, Ali NN, Saer CHJ, Eeckhout Y, Vaes G 1987 The effects of inhibitors of cysteine-proteinases and collagenase on the resorptive activity of isolated osteoclasts. Bone 8:305-313.
6. Everts V, Beertsen W, Schröder R 1988 Effects of the proteinase inhibitors leupeptin and E-64 on osteoclastic bone resorption. Calcif Tissue Int 43:172-178.
7. Everts V, Delaissé JM, Korper W, Niehof A, Vaes G, Beertsen W 1992 Degradation of collagen in the bone-resorbing compartment underlying the osteoclast involves both cysteine-proteinases and matrix metalloproteinases. J Cell Physiol 150:221-231.
8. Van Noorden CJF, Everts V 1991 Selective inhibition of cysteine proteinases by Z-Phe-AlaCH2F suppresses digestion of collagen by fibroblasts and osteoclasts. Biochem Biophys Res Commun 178:178-184.
9. Lerner UH, Grubb A 1992 Human cystatin C, a cysteine proteinase inhibitor, inhibits bone resorption in vitro stimulated by parathyroid hormone and parathyroid hormone-related peptide of malignancy. J Bone Miner Res 7:433-440.
10. Goto T, Tsukuba T, Kiyoshima T, Nishimura Y, Kato K, Yamamoto K, Tanaka T 1993 Immunohistochemical localization of cathepsins B, D and L in the rat osteoclast. Histochemistry 99:411-414.
11. Goto T, Kiyoshima T, Moroi R, Tsukuba T, Nishimura Y, Himeno M, Yamamoto K, Tanaka T 1994 Localization of cathepsin B, cathepsin D, and cathepsin L in the rat osteoclast by immunolight and immuno-electron microscopy. Histochemistry 101:33-40.
12. Hill PA, Buttle DJ, Jones SJ, Boyde A, Murata M, Reynolds JJ, Meikle MC 1994 Inhibition of bone resorption by selective inactivators of cysteine proteinases. J Cell Biochem 56:118-130.
13. Debari K, Sasaki T, Udagawa N, Rifkin BR 1995 An ultra-structural evaluation of the effects of cysteine-proteinase inhibitors on osteoclastic resorptive functions. Calcif Tissue Int 56:566-570.
14. Fuller K, Chambers TJ 1995 Localisation of mRNA for collagenase in osteocytic, bone surface and chondrocytic cells but not osteoclasts. J Cell Sci 108:2221-2230.
15. Holliday LS, Welgus HG, Flissart CJ, Veith GM, Jeffrey JJ, Gluck SL 1997 Initiation of osteoclast bone resorption by interstitial collagenase. J Biol Chem 272:22053-22068.
16. Delaissé JM, Eeckhout Y, Sear C, Galloway A, McCullagh K, Vaes G 1985 A new synthetic inhibitor of mammalian tissue collagenase inhibits bone resorption in culture. Biochem Biophys Res Commun 133:483-490.
17. Delaissé JM, Eeckhout Y, Neff L, Francois-Gillet Ch, Henriet P, Su Y, Vaes G, Baron R 1993 (Pro) collagenase (matrix metalloproteinase-1) is present in rodent osteoclasts and in the underlying bone-resorbing compartment. J Cell Sci 106:1071-1082.
18. Hill PA, Murphy G, Docherty AJP, Hembry RM, Millican TA, Reynolds JJ, Meikle MC 1994 The effects of selective inhibitors of matrix metalloproteinases (MMPs) on bone resorption and the identification of MMPs and TIMP-1 in isolated osteoclasts. J Cell Sci 107:3055-3064.
19. Okamura T, Shimokawa H, Takagi Y, Ono H, Sasaki S 1993 Detection of collagenase mRNA in odontoclasts of bovine root-resorbing tissue by in situ hybridization. Calcif Tissue Int 52:325-330.
20. Reponen P, Sahlberg C, Munaut C, Thcsleff I, Tryggvason K 1994 High expression of 92-kD type IV collagenase (gelatinase B) in the osteoclast lineage during mouse development. J Cell Biol 124:1091-1102.
21. Tezuka K, Nemoto K, Tezuka Y, Sato T, Ikeda Y, Kobori M, Kawashima H, Eguchi H, Hakeda Y, Kumegawa M 1994 Identification of matrix metalloproteinase 9 in rabbit osteoclasts. J Biol Chem 269:15006-15009.
22. Okada Y, Naka K, Kawamura K, Matsumoto T, Nakanishi I, Fujimoto N, Sato H, Seiki M 1995 Localization of matrix metalloproteinase 9 (92-kilodalton gelatinase/type IV collagenase = gelatinase B) in osteoclasts: Implications for bone resorption. Lab Invest 72:311-322.
23. Shimizu H, Sakamoto M, Sakamoto S 1990 Bone resorption by isolated osteoclast in living versus devitalized bone: Differences in mode and extent and the effects of recombinant tissue inhibitor of metalloproteinases. J Bone Miner Res 5:411-418.
24. Rifkin BR, Vernillo AT, Golub LM 1993 Blocking periodontal disease progression by inhibiting tissue-destructive enzymes: A potential therapeutic role for tetracyclines and their chemically-modified analogs. J Periodontol 64:819-827.
25. Hill PA, Docherty AJ, Bottomley KM, O'Connell JP, Morphy JR, Reynolds JJ, Meikle MC 1995 Inhibition of bone resorption in vitro by selective inhibitors of gelatinase and collagenase. Biochem J 308:167-175.
26. Silver IA, Murrills RJ, Etherington DJ 1988 Microelectrode studies on the acid microenvironment beneath adherent macrophages and osteoclasts. Exp Cell Res 175:266-276.
27. Scott JE, Haigh M 1988 Identification of specific binding sites for keratan sulphate proteoglycans and chondroitin-dermatan sulphate proteoglycans on collagen fibrils in cornea by the use of cupromeronic blue in 'critical-electrolyte-concentration' techniques. Biochem J 253:607-610.
28. Lelièvre Y, Bouboutou R, Boiziau J, Faucher D, Achard D, Cartwright T 1990 Low molecular weight, sequence base, collagenase inhibitors block the interaction between collagenase and TIMP (tissue inhibitor of metalloproteinases). Matrix 10: 292-299.
29. Creemers LB, Jansen DC, Docherty AJP, Reynolds JJ, Beertsen W, Everts V 1998 Gelatinase A (MMP-2) and cysteine proteinases are essential for the degradation of collagen in soft connective tissue. Matrix Biol 17:35-46.
30. Kirschke H, Wikstrom P, Shaw E 1988 Active center differences between cathepsins L and B: The S1 binding region. FEBS Lett 228:128-130.
31. Buttle DJ, Murata M, Knight CG, Barrctt AJ 1992 CAO74 methyl ester: A proinhibitor for intracellular cathepsin B. Arch Biochem Biophys 299:377-380.
32. Delaissé JM, Ledent P, Eeckhout Y, Vaes G 1986 Cysteine proteinases and bone resorption. In: Turk V (ed.) Cysteine Proteinases and Their Inhibitors. Walter de Gruyter & Co., Berlin, Germany, pp. 259-268.
33. Reich R, Thompson EW, Iwamoto Y, Martin GR, Deason JR, Fuller GC, Miskin R 1988 Effects of inhibitors of plasminogen activator, serine proteinases, and collagenase IV on the invasion of basement membranes by metastatic cells. Cancer Res 48:3307-3312.
34. Caputo CB, Sygowski LA, Patton SP, Wolanin DJ, Shaw A, Roberts RA, DiPasquale G 1988 Protease inhibitors decrease rabbit cartilage degradation after meniscectomy. J Orthop Res 6:103-108.
35. Delaissé JM, Eeckhout Y, Vaes G 1988 Bone-resorption agents affect the production and distribution of procollagenase as well as the activity of collagenase in bone tissue. Endocrinology 123:264-276.
36. Raisz LG, Simmons HA, Thompson WJ, Shepard KL, Anderson PS, Rodan GA 1988 Effects of a potent carbonic anhydrase inhibitor on bone resorption in organ culture. Endocrinology 122:1083-1086.
37. Lerner UH 1982 Indomethacin inhibits bone resorption in vitro without affecting bone collagen synthesis. Agents Actions 12:466-470.
38. Katz JM, Skinner SJM, Wilson T, Gray DH 1993 The in vitro effect of indomethacin on basal bone resorption, on prostaglandin production and on the response to added prostaglandins. Prostaglandins 26:545-555.
39. Blavier L, Delaissé JM 1995 Matrix metalloproteinases are obligatory for the migration of preosteoclasts to the developing marrow cavity of primitive long bone. J Cell Sci 108:3649-3659.
40. Sato T, Foged NT, Delaissé JM 1998 The migration of purified osteoclasts through collagen is inhibited by MMP inhibitors. J Bone Miner Res 13 (in press).
41. Kozaci LD, Buttle DJ, Hollander AP 1997 Degradation of type II collagen, but not proteoglycan, correlates with matrix metalloproteinase activity in cartilage expiant cultures. Arthritis Rheum 40:164-174.
42. Nguyen Q, Mort JS, Roughley PJ 1990 Cartilage proteoglycan aggregate is degraded more extensively by cathepsin L than by cathepsin B. Biochem J 266:569-573.
43. Eeckhout Y 1990 Possible role and mechanism of action of dissolved calcium in the degradation of bone collagen by lysosomal cathepsins and collagenase. Biochem J 272:529-532.
44. Etherington DJ, Birkedahl-Hansen H 1987 The influence of dissolved calcium salts on the degradation of hard-tissue collagens by lysosomal cathepsin. Collagen Rel Res 7:185-199.
45. Inaoka T, Bilbe G, Ishibashi O, Tezuka K, Kumegawa M, Kokubo T 1995 Molecular cloning of human cDNA for cathepsin K: Novel cysteine proteinase predominantly expressed in bone. Biochem Biophys Res Commun 206:89-96.
46. Brömme D, Okamoto K, Wang BB, Biroc S 1996 Human cathepsin O2, a matrix protein-degrading cysteine protease expressed in osteoclasts: Functional expression of human cathepsin O2 in Spodoptera frugiperda and characterization of the enzyme. J Biol Chem 271:2126-2132.
47. Gelb BD, Shi GP, Chapman HA, Desnick RJ 1996 Pycnodysostosis, a disease caused by cathepsin K deficiency. Science 273:1236-1238.
48. Everts V, Aronson DC, Beertsen W 1985 Phagocytosis of bone collagen by osteoclasts in two cases of pycnodysotosis. Calcif Tissue Int 37:25-31.
49. Rice DPC, Kirm HJ, Thesleff I 1997 Detection of gelatinase B expression reveals osteoclastic bone resorption as a feature of early calvarial bone development. Bone 21:479-486.